Physician profile
Jonathan M Cox
NPI 1013987544
$4,804.31
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,737 · 2020: $1,241 · 2021: $1,578 · 2022: $248.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $741.39 | 2019-2021 | |
| Pfizer INC. | $568.15 | 2019-2021 | |
| Amarin Pharma, INC. | $532.55 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $523.27 | 2019-2021 | |
| Boston Scientific Corporation | $417.66 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $403.73 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $255.02 | 2019-2022 | |
| Janssen Biotech, INC. | $171.99 | 2019-2021 | |
| Astellas Pharma US INC | $158.79 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $145.63 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $133.91 | 2019-2022 | |
| Esperion Therapeutics, INC. | $125.46 | 2021 | |
| Gilead Sciences, INC. | $112.37 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $107.30 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $91.07 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $76.85 | 2019-2021 | |
| Althera Pharmaceuticals LLC | $65.85 | 2021 | |
| Merck Sharp & Dohme LLC | $57.41 | 2021 | |
| Impulse Dynamics (USA) INC. | $46.28 | 2022 | |
| Abbott Laboratories | $34.70 | 2019-2021 | |
| Medtronic, INC. | $22.35 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $12.58 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.